No post dil? No problem! #ShockwaveIVL was effective at reducing lesions stenosis with minimal post dil & stenting in the #DisruptBTKII Study. Dr Raghuram Lakshminarayan, Prof Andrew Holden & Dr Nick West discuss acute outcomes: https://lnkd.in/gvRBeXH8 US Rx only. Important Safety Information: http://bit.ly/3iEq7fC
Shockwave Medical
Medical Equipment Manufacturing
Santa Clara, California 93,191 followers
Making waves for underserved patients with cardiovascular disease via novel technologies. ⚡🌊
About us
Shockwave Medical is revolutionizing the interventional treatment of advanced cardiovascular disease by developing technology that targets calcified plaque. Inspired by 30-years of safety and efficacy in kidney stone treatment, our Intravascular Lithotripsy family of catheters delivers localized lithotripsy at the site of cardiovascular calcium that enables gentle balloon dilatation of calcified, stenotic arteries. IVL catheters use sonic pressure waves to preferentially impact hard tissue, disrupting calcium, while leaving soft tissue undisturbed. An integrated balloon catheter then dilates the calcified lesion at low-pressure, restoring blood flow. Stay connected with us at www.ShockwaveMedical.com and on Twitter @ShockwaveIVL
- Website
-
http://shockwavemedical.com
External link for Shockwave Medical
- Industry
- Medical Equipment Manufacturing
- Company size
- 1,001-5,000 employees
- Headquarters
- Santa Clara, California
- Type
- Public Company
Locations
-
Primary
5403 Betsy Ross Dr
Santa Clara, California 95054, US
Employees at Shockwave Medical
-
Lori Dossola Lyle
Marketing at Shockwave Medical, Inc.
-
Erika Johnson
-
Bharath Natarajan
Senior Director, Data Platform and Business Intelligence
-
Jason Shields
Medical Device Executive | General Management | Commercial Execution | Marketing | Professional Education | Business Development | Digital Surgery
Updates
-
How did you personally find out about #ShockwaveIVL and incorporate it into your patient treatment algorithm? Hear from Dr Ankur Lodha, an IC from Cardiovascular Institute of the South. US Rx only. Important Safety Information: http://bit.ly/3iEq7fC #ShockwaveP2P
-
Elevate your expectations of the efficacy of #ShockwaveIVL in treating challenging calcific disease. In this EuroIntervention publication, #CoronaryIVL was highly effective in treating calcified nodules, consistently crossing and facilitating therapy in all cases. Read here: https://lnkd.in/gkgbq4gJ US Rx only. Important Safety Information: http://bit.ly/3iEq7fC
-
Despite a complex patient and lesion cohort, angiographic complications are low in the #DisruptBTKII Study. Dr Raghuram Lakshminarayan & Prof Andrew Holden discuss how the safety profile of #ShockwaveIVL impacts treatment: https://lnkd.in/gvRBeXH8 US Rx only. Important Safety Information: http://bit.ly/3iEq7fC
-
#ShockNation spent the day saving the waves! 🌊✨ Huge kudos to the Shockwave volunteers at our Annual Beach Cleanup who collected 10 pounds of waste and 1,485 cigarette butts. Considering how much of the waste weighed almost nothing, we’re proud of our team’s big impact! Learn more about the Pacific Beach Coalition and how you can help them make waves too: https://lnkd.in/grD4jhtv #JNJMedTechProud #ShockOn
-
#ShockwaveIVL is supporting the next generation of interventional cardiologists. Don’t miss out on this amazing opportunity to get critical funding through the #SCAI / Shockwave Medical Early Career Research Grant! Applicants must be SCAI members who are within 10 years of completing an interventional cardiology fellowship. Applications accepted now through Jan 21, 2025. Learn more and apply today: https://lnkd.in/dtKHpMtf US Rx only. Important Safety Information: http://bit.ly/3iEq7fC
-
Cracking news, 2-year follow up to the #DisruptCAD studies, #CoronaryIVL demonstrated consistent effectiveness treating calcified nodules, with comparable MSA or stent expansion between CN and non-CN groups. Read the publication to see how #ShockwaveIVL can act as a frontline therapy for this complex disease state: https://lnkd.in/gkgbq4gJ US Rx only. Important Safety Information: http://bit.ly/3iEq7fC
-
New 30-day data confirm #ShockwaveIVL impact BTK. DISRUPT BTK II 30-day results further confirm IVL's safety profile in challenging calcium below the knee, demonstrated by low rates of MALE or POD. See Results: https://lnkd.in/dEgJVERX US Rx only. Important Safety Information: http://bit.ly/3iEq7fC
-
Dr Raghuram Lakshminarayan & Prof Andrew Holden share their perspectives from the #DisruptBTKII Acute Outcomes with Shockwave Medical CMO Dr Nick West. Hear how #ShockwaveIVL effectively treats tough calcium below-the-knee: https://lnkd.in/gvRBeXH8 US Rx only. Important Safety Information: http://bit.ly/3iEq7fC
-
See Dr Jason Wollmuth from Providence St Vincents use #All120 pulses of the #ShockwaveC2plus catheter to modify eccentric and concentric calcification in the mid LAD. Learn more about Shockwave C2+ here: https://lnkd.in/d84J_dq5 US Rx only. Important Safety Information: http://bit.ly/3iEq7fC
Learn more about Shockwave C2+